Strs Ohio lessened its holdings in Colgate-Palmolive (NYSE:CL) by 2.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 465,047 shares of the company’s stock after selling 12,737 shares during the quarter. Strs Ohio owned approximately 0.05% of Colgate-Palmolive worth $35,087,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also modified their holdings of the stock. ST Germain D J Co. Inc. grew its position in Colgate-Palmolive by 18.3% in the 2nd quarter. ST Germain D J Co. Inc. now owns 3,815 shares of the company’s stock valued at $283,000 after purchasing an additional 590 shares during the period. Enterprise Financial Services Corp boosted its holdings in Colgate-Palmolive by 24.8% during the 2nd quarter. Enterprise Financial Services Corp now owns 3,238 shares of the company’s stock worth $240,000 after acquiring an additional 644 shares during the last quarter. Crestwood Advisors Group LLC boosted its holdings in Colgate-Palmolive by 1.1% during the 2nd quarter. Crestwood Advisors Group LLC now owns 216,475 shares of the company’s stock worth $15,704,000 after acquiring an additional 2,334 shares during the last quarter. Sei Investments Co. boosted its holdings in Colgate-Palmolive by 60.4% during the 2nd quarter. Sei Investments Co. now owns 110,058 shares of the company’s stock worth $8,158,000 after acquiring an additional 41,430 shares during the last quarter. Finally, YHB Investment Advisors Inc. boosted its holdings in Colgate-Palmolive by 9.7% during the 2nd quarter. YHB Investment Advisors Inc. now owns 54,751 shares of the company’s stock worth $4,059,000 after acquiring an additional 4,861 shares during the last quarter. Institutional investors and hedge funds own 72.85% of the company’s stock.
Colgate-Palmolive (CL) opened at $69.97 on Thursday. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.34 and a current ratio of 0.47. The company has a market capitalization of $61,730.80, a P/E ratio of 30.54, a P/E/G ratio of 2.60 and a beta of 0.75. Colgate-Palmolive has a twelve month low of $68.03 and a twelve month high of $77.91.
The business also recently announced a quarterly dividend, which will be paid on Thursday, February 15th. Stockholders of record on Tuesday, January 23rd will be paid a $0.40 dividend. The ex-dividend date is Monday, January 22nd. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.29%. Colgate-Palmolive’s dividend payout ratio is currently 70.18%.
In other Colgate-Palmolive news, Vice Chairman Franck J. Moison sold 30,000 shares of the firm’s stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $69.70, for a total value of $2,091,000.00. Following the transaction, the insider now directly owns 211,048 shares of the company’s stock, valued at $14,710,045.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Mukul Deoras sold 7,150 shares of the firm’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $70.03, for a total value of $500,714.50. The disclosure for this sale can be found here. Over the last three months, insiders sold 414,019 shares of company stock worth $29,541,377. Insiders own 1.02% of the company’s stock.
A number of equities research analysts have recently commented on the company. Zacks Investment Research upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $84.00 target price on the stock in a research note on Monday, January 8th. Macquarie upgraded Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price objective on the stock in a research note on Tuesday, December 19th. BNP Paribas cut Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a research note on Tuesday, January 30th. Citigroup upped their price target on Colgate-Palmolive from $75.00 to $80.00 and gave the company a “neutral” rating in a research report on Tuesday, January 30th. Finally, Deutsche Bank initiated coverage on Colgate-Palmolive in a research report on Wednesday, December 13th. They set a “hold” rating and a $75.00 price target on the stock. Three research analysts have rated the stock with a sell rating, eleven have given a hold rating and five have given a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $77.71.
COPYRIGHT VIOLATION WARNING: This report was originally published by Week Herald and is the property of of Week Herald. If you are reading this report on another site, it was illegally copied and republished in violation of international copyright and trademark legislation. The correct version of this report can be read at https://weekherald.com/2018/02/15/strs-ohio-sells-12737-shares-of-colgate-palmolive-cl.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.